Home > Diagnosing dementia in the clinical setting: can amyloid PET provide additional value over cerebrospinal fluid?
Diagnosing dementia in the clinical setting: can amyloid PET provide additional value over cerebrospinal fluid?
Manuscript Number:
16-0302R2
Author(s):
Anna Barnes, Jamshed Bomanji, John Dickson, Nick C. Fox, Irfan Kayani, Michael P. Lunn, Catherine J. Mummery, Ross W. Paterson, Martin N. Rossor, Jonathan M. Schott, Jason D. Warren, Philip S.J. Weston, Henrik Zetterberg